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Objective: To investigate the distribution of pathogens and drug resistance in bile and
the association between the pregnane X receptor (PXR) gene polymorphisms, traditional
Chinese medicine (TCM) syndromes and the risk of cholesterol gallstone disease (CGD).
Methods: A total of 392 samples were enrolled in this study from January 2014 to
February 2015, among which 192 patients were with CGD, and 200 samples were
healthy. Strains were isolated and susceptibility testing was the disk diffusion method
susceptibility testing. The patients were divided into hepatochlic hygropyrexia, stagnation
of liver-qi, and the accumulation of damp. The PXR gene polymorphisms were analyzed
by polymerase chain reaction-restriction fragment length polymorphism. The association
between the PXR gene polymorphisms and the risk of CGD was examined by logistic
regression analysis.
Results: A total of 192 cases were detected in 230 of bile culture pathogens, including
Gram-negative bacteria 133 (57.83%), Gram-positive bacteria 76 (33.04%), and fungi 21
(9.13%). The top ﬁve pathogens were Escherichia coli, Klebsiella pneumoniae,
Enterococcus faecalis, Candida albicans, and Enterococcus feces, of which 110 cases
was of single infection, 48 cases of mixed infection of two strains, eight cases of mixed
infection of three bacteria. Among 59 Escherichia coli, the yield extended-spectrum beta-
lactamases had 40 (67.80%). The hepatochlic hygropyrexia was the most TCM syn-
drome, followed by stagnation of liver-qi, and the accumulation of damp was least.
Different pathogens and the rs6785049 genotypes distributed differently in cholelithiasis
patients with different TCM syndromes (P < 0.05). In hepatochlic hygropyrexia patients
the Gram-negative bacteria was most. There was signiﬁcant differences between CGD
group and control group in rs6785049 (P < 0.001). Comparison with wild-type portable
GG, GA genotype increased the risk of the occurrence of gallstones (OR = 0.40, 95%CI:
0.16–0.79); likewise, carrying the GA+AA genotype also increased the risk (OR = 0.38,
95%CI: 0.19–0.81). There was no signiﬁcant differences in rs2276707, rs3814055 site
polymorphic loci alleles in CGD group and control group.rticle under the CC BY-NC-ND license (http://
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bacterial culture and sensitivity test, and drugs should be strictly chosen based on the
results. The rs6785049 polymorphisms in PXR gene may increase the risk of gallstones
ontogeny, and gallstones can be early detected and prevented by detecting genotypes.
rs6785049 polymorphisms in PXR gene may has relationship with TCM syndromes.1. Introduction
Cholelithiasis, also known as cholesterol gallstone disease,
involves the formation of gallstones that disrupt the proper
draining of bile from the gallbladder. Symptoms include a
swollen, painful abdomen, radiating pain, yellowing skin, and
sometimes fever. Improved living conditions and nutritional
status among the Chinese has contributed to an increase in
cholelithiasis in recent years [1]. The formation of gallstones has
been linked to a variety of environmental and dietary factors,
and some studies suggest that genetics also play a role [2].
Speciﬁcally, the pregnane X receptor (PXR) has been found to
be closely associated with cholelithiasis, as PXR gene
polymorphisms have been shown to reduce the risk of
gallbladder and bile duct stone formation [3–6]. PXR is a
member of the nuclear receptor subfamily and numerous
studies have found that alterations to the PXR gene can affect
cholesterol metabolism, reduce gallbladder motility, inﬂuence
the excretion of bile and cholesterol, and regulate the
cholesterol saturation index so as to affect the formation of
gallstones [3,7–11].
According to traditional Chinese medicine (TCM), chronic
gallstone formation is the result of qi stagnation, blood stasis,
and accumulation of ﬂuid in the body, or dampness [12]. TCM
suggests that the pathogenesis of chronic cholelithiasis
involves the invasion of exogenous factors via skin, hair, or
interstices of the ﬂesh into the interpleuro-diaphragmatic
space, where they then accumulate and interfere with bile
drainage [13]. The accumulated and stagnated bile then leads to
the formation of stones. Emotional disorders may also
contribute to the stagnation of the liver qi and qi depression in
the gallbladder, further resulting in stagnated bile. Additional
causes may be related to excess phlegm, blood extravasation,
or roundworm stagnation in the liver and gallbladder, causing
poor bile excretion and coagulation into stones. These factors
may act alone, or in combination.
The relationship between bile duct bacterial strains and TCM
syndrome differentiation related to cholelithiasis was assessed in
this study, and the role of PXR gene polymorphisms in the
development of cholelithiasis was also determined. Bile bacterial
cultures and blood samples collected from cholelithiasis patients
were compared to samples from healthy individuals and the
bacteria were subjected to antibiotic screening.
2. Materials and methods
2.1. Study participants
Samples from 192 patients with cholelithiasis treated in our
hospital between January 2014 and February 2015 were selected
for this study. The patient group was made up of 110 males(57.29%) and 82 females (42.71%), with an average age of
(61.18 ± 9.72) years. The diagnosis of all 192 patients was
clinically conﬁrmed, and 200 healthy individuals receiving
physical examination during the same period in our hospital
were selected as a control group. The control group was made up
of 118 males (59.00%) and 82 females (41.00%), with an
average age of (60.35 ± 8.16) years. There were no statistically
signiﬁcant differences in gender or age between the case group
and the control group. All patients and healthy participants were
Han Chinese. This study was approved by the Ethics Committee
of Afﬁliated Hospital of Hainan Medical University and
informed consent was obtained from all participants.
2.2. Identiﬁcation of bacterial strains
A total of 4–6 mL bile were collected from patients and
placed in sterile culture tubes. Each sample was divided into two
portions; one to be used for bacterial culture and drug sensitivity
testing and another for anaerobic culture. Strain identiﬁcation
was performed according to the National Clinical Laboratory
Procedures manual. A VITEK-2 Compact Automated Bacteria
Analyzer (bioMerieux, France) was used to perform drug
sensitivity testing using a paper strip. Drug sensitivity determi-
nation was performed in accordance with the Executive Standard
for Sensitivity Testing for Antimicrobial Drugs published by the
Clinical and Laboratory Standards Institute.
2.3. Antibiotic resistance test
Antibiotic resistance was determined among Escherichia coli
(E. coli) and Klebsiella pneumoniae samples by testing for the
presence of extended-spectrum beta-lactamases (ESBLs) using
the disk diffusion test recommended by the Clinical and Labo-
ratory Standards Institute.
2.4. PXR gene polymorphism determination
Genomic DNA was extracted using phenol/chloroform and
polymerase chain reaction (PCR) restriction fragment length
polymorphism was used to determine the PXR gene poly-
morphism. Genotyping was performed as follows: rs2276707:
upstream PCR primer 50CTGAGAAGCTGCCCCTCGAT30,
downstream PCR primer: 50CTCATGCAGCTGCA
GCTTCTTC30; annealing temperature: 57 C; restriction endo-
nuclease: Mbo I. rs6785049: upstream primer: 50CCCA
TAATCCAGAAGTTGGGCG30, downstream primer: 50GCA
GAGCTGTCTGCTGGGTTGT30; annealing temperature:
51 C; restriction endonuclease: Hin6 I. rs3814055: upstream
primer 50TCATTTTTTGGCAATCCCAGGAT30, downstream
primer: 50TCTGGCAACAGTAAAGCAGGGG30; annealing
temperature: 50 C; restriction endonuclease: Mbo I.
Table 1
Bile pathogen distribution in cholelithiasis disease.
Pathogens n % Of total cases
Gram-negative bacteria 133 57.83
Escherichia coli 59 25.65
Klebsiella pneumoniae 17 7.39
Enterobacter cloacae 12 5.22
Bacteroides fragilis (anaerobic) 12 5.22
Enterobacter birth 9 3.91
Acinetobacter baumannii 8 3.48
Pang proteus 7 3.04
Other gram-negative bacteria 9 3.91
Gram-positive bacteria 76 33.04
Enterococcus faecalis 16 6.96
Feces Enterococcus 13 5.65
Streptococcus viridans 9 3.91
Lead yellow Enterococcus 8 3.48
Quail chicken Enterococcus 7 3.04
Clostridium perfringens (anaerobic) 6 2.61
Streptococcus anaerobic digestion
(anaerobic)
6 2.61
Hard acid bacteria (anaerobic) 6 2.61
Other Gram-positive bacteria 5 2.17
Fungus 21 9.13
Candida albicans 16 6.96
Candida tropicalis 5 2.17
Total 230 100.00
Table 2
Antibiotic resistance of Gram-negative bacilli.
Antibacterials Escherichia coli Klebsiella pneumoniae
Investigated
number (n)
Number and
resistance
rates [(n)%]
Investigated
number (n)
Number and
resistance
rates [(n)%]
Ampicillin 59 50 (84.75) 17 17 (100.00)
Sulbactam 42 23 (54.76) 13 8 (61.54)
Amikacin 59 3 (5.08) 17 3 (17.65)
Aztreonam 59 32 (54.24) 17 7 (41.18)
Nitrofurantoin 59 10 (16.95) 17 5 (29.41)
Ertapenem 55 0 (0.00) 17 0 (0.00)
Amoxicillin 59 10 (16.95) 17 11 (64.71)
Trimethoprim 59 38 (64.41) 17 15 (88.24)
Ciproﬂoxacin 59 49 (83.05) 17 11 (64.71)
Meropenem 53 0 (0.00) 16 0 (0.00)
Tazobactam 59 2 (3.39) 17 3 (17.65)
Cefepime
waning
59 25 (42.37) 17 5 (29.41)
Gentamicin 59 22 (37.29) 17 5 (29.41)
Cefoperazone 56 1 (1.79) 17 4 (23.53)
Ceftriaxone 59 44 (74.58) 17 14 (82.35)
Ceftazidime 57 24 (42.11) 17 8 (47.06)
Cefoxitin 59 12 (20.34) 17 4 (23.53)
Cefazolin 59 48 (81.36) 17 15 (88.24)
Tobramycin 59 13 (22.03) 17 5 (29.41)
Imipenem 51 0 (0.00) 17 0 (0.00)
Tigecycline 50 0 (0.00) 15 0 (0.00)
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primers (0.3 mL), 0.8 mmol/L dNTPs, 1.5 mmol/L MgCl2, 80 mg/
mL genomic DNA, 0.5 unit of REDTaq DNA polymerase, and
15.7 mL H2O. A PTC 200 Therma Cycler (Promega Corporation,
USA) was used to perform the reactions. Each PCR reaction
involved denaturing at 95 C for 5 min, followed by 35 cycles at
95 C, each for 30 s, annealing at 70 C, and extension at 70 C
for 45 s. For restriction fragment length polymorphism analysis,
the PCR products of rs2276707, rs6785049, and rs3814055 were
digested with Mbo I, Hin6 I, and Mbo I endonuclease, respec-
tively. PCR products were electrophoresed in 2% sepharose gel
and stained with ethidium bromide for band visualization.
2.5. TCM syndrome differentiation
Cholelithiasis patients were divided into three types accord-
ing to the Guiding Principles for Clinical Research on New
Drugs of TCM and Speciﬁcations for TCM Syndrome, pub-
lished by the Chinese Ministry of Health. Patients were deter-
mined to have dampness-heat syndrome of the liver and
gallbladder based on the presence of yellow urine, bitter taste in
the mouth, fullness and distention or paroxysmal pain of the
lateral thorax, occasional unbearable angina extending to back
and shoulder, loss of appetite, yellowness of body and eye,
constipation, yellow and greasy tongue coating, and wiry pulse.
Hepatic qi stagnation was determined based on the presence of
signiﬁcant angina at the right lateral thorax or under the xiphoid
process, lateral thorax pain or angina radiating to the back,
nausea, vomiting, loss of appetite, bitter taste, dry mouth,
aversion to greasy foods. Some patients also suffered from fever,
ﬁery temperament, irritability, hiccups, belching, dark red
tongue, thin yellow or thin white tongue coating, and thread,
slippery pulses. Noxious dampness accumulation was deter-
mined by the presence of fever and aversion to cold or alter-
nating episodes of fever and chills, unbearable pain below the
right lateral thorax, abdominal tenderness, tension of abdominal
muscles, bitter taste, dry throat, yellow body and eyes, cold
limbs, in severe cases, coma and delirium, red or crimson
tongue, yellow dry tongue coating, and slippery, rapid pulses.
2.6. Statistical analysis
Epidata 3.1 (Epidata Software, Denmark) was used to create
a database for data entry using the double entry method, fol-
lowed by logic checks. SAS 9.2 (SAS Institute, USA) was used
for data processing. The statistical methods used to analyze data
were the c2 test and non-conditional logistic regression analysis.
A P < 0.05 was considered to be statistically signiﬁcant.
3. Results
3.1. Pathogenic bacteria distribution
A total of 230 strains of pathogenic bacteria were detected
among the bile cultures, including 133 strains of Gram-negative
bacteria (57.83%) and 76 strains of Gram-positive bacteria
(33.04%), as well as 21 strains of fungus (9.13%). The ﬁve most
common organisms were E. coli, Klebsiella pneumoniae,
Enterococcus faecalis, Candida albicans, and Enterococcus fae-
cium. There were 110 cases of single-fungus infection, 48 cases ofmixed infection of two bacteria, and eight cases of mixed infection
involving at least three types of bacteria and/or fungus (Table 1).
3.2. Antibiotic resistance among bile bacteria cultures
Fifty-nine strains of E. coli were identiﬁed among the chole-
lithiasis patients and 40 tested positive for ESBLs (67.8%). Gram-
negative bacteria were resistant to ampicillin, nitrofurantoin,
erythromycin, ciproﬂoxacin, and ceftriaxone, while remainingLevoﬂoxacin 59 47 (79.66) 17 15 (88.24)
Table 3
Antibiotic resistance of enterococci.
Antibacterials Enterococcus faecalis Feces Enterococcus
Investigated
number (n)
Number and
resistance
rates [(n)%]
Investigated
number (n)
Number and
resistance
rates [(n)%]
Ampicillin 16 6 (37.50) 13 9 (69.23)
Nitrofurantoin 15 0 (0.00) 13 3 (23.08)
Erythromycin 16 4 (25.00) 13 13 (100.00)
Ciproﬂoxacin 16 2 (12.50) 13 9 (69.23)
Clindamycin 14 14 (100.00) 13 13 (100.00)
Quinupristin 16 16 (100.00) 13 0 (0.00)
Linezolid 16 0 (0.00) 13 1 (7.69)
Streptomycin
(high units)
14 2 (14.29) 13 9 (69.23)
Moxiﬂoxacin 16 2 (12.50) 13 8 (61.54)
Penicillin G 15 5 (33.33) 13 9 (69.23)
Gentamicin 15 4 (26.67) 13 6 (46.15)
Tetracycline 16 8 (50.00) 13 5 (38.46)
Teicoplanin 16 0 (0.00) 12 0 (0.00)
Tigecycline 16 0 (0.00) 13 1 (7.69)
Levoﬂoxacin 16 3 (18.75) 13 7 (53.85)
Vancomycin 15 1 (6.67) 13 2 (15.38)
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were highly sensitive to teicoplanin, linezolid, nitrofurantoin, and
tigecycline. Enterococcus faecalis was highly resistant to clinda-
mycin and quinupristin, while Enterococcus faecium was highly
sensitive to erythromycin, clindamycin, levoﬂoxacin, and cipro-
ﬂoxacin. Complete drug resistance proﬁles among Gram-negative
and Enterococcus bacteria were shown in Tables 2 and 3.
3.3. Correlation of bacterial strain and pregnane
receptor gene polymorphism with TCM syndrome
identiﬁcation
TCM diagnostic factors identiﬁed dampness and heat in the liver
and gallbladder as the prevailing syndrome of cholelithiasis patients,
followed by hepatic qi stagnation, with the smallest number of pa-
tients showing signs of noxious dampness accumulation. Different
bacterial strains from cholelithiasis patients were signiﬁcantly associ-
ated with the syndromes identiﬁed by TCM (P < 0.05), and Gram-
negative bacteria were detected in the largest number of patients
with dampness and heat of the liver and gallbladder.
The rs6785049 genotype of the PXR gene was found to be
signiﬁcantly associated with TCM syndromes (P < 0.05), while
there was no statistically signiﬁcant difference observed in the
distribution of the rs2276707 and rs3814055 genotype. The
results were shown in Table 4.
3.4. PXR gene polymorphism linked to cholelithiasis
The only genotype to show signiﬁcant association with
cholelithiasis diagnosis was the rs6785049 polymorphism
(P < 0.001), and after combining GA and AA, there was still
statistically signiﬁcant difference between the combined geno-
type and GG (P < 0.001). Logistic regression analysis indicated
that the GA genotype within the rs6785049 polymorphism
carried an increased risk of gallstones compared to those car-
rying the GG wild type genotype (OR = 0.40, 95%CI: 0.16–
0.79). Individuals carrying the GA+AA genotype were also at
increased risk of gallstones (OR = 0.38, 95%CI: 0.19–0.81).
Table 5
Genotype and allele frequencies among cases and controls and their as-
sociation with cholelithiasis risk [(n)%].
Genotype Cholelithiasis
(n = 192)
Control
(n = 200)
P OR (95%CI)
rs2276707
CC 35 (18.23) 32 (16.00) 0.3870 1
CT 106 (55.21) 124 (62.00) 0.13 (0.58.2.0)
TT 51 (26.56) 44 (22.00) 0.89 (0.61.1.8)
CT+TT 157 (81.77) 168 (84.00) 0.5580 1.25 (0.71.2.1)
rs3814055
CC 84 (43.75) 90 (45.00) 0.9550 1
CT 67 (34.90) 67 (33.50) 0.99 (0.43.1.5)
TT 41 (21.35) 43 (21.50) 1.02 (0.48.1.8)
CT+TT 108 (56.25) 110 (55.00) 0.8030 0.98 (0.55.1.67)
rs6785049
GG 31 (16.15) 68 (34.00) 0.0002 1
GA 125 (65.10) 106 (53.00) 0.40 (0.16.0.7)
AA 36 (18.75) 26 (13.00) 0.31 (0.14.0.7)
GA+AA 161 (83.85) 132 (66.00) <0.0001 0.38 (0.19.0.8)
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polymorphism was correlated with risk of cholelithiasis. The
results were shown in Table 5.
4. Discussion
Culturing of the bile bacteria collected in this study revealed
a high rate of mixed infections (56 cases), higher than that
previously reported in Chinese patients [14], and a low rate of
fungal infection. Our discovery of Enterococcus faecalis and
Enterococcus faecium in the bile of cholelithiasis patients
conﬁrm previous ﬁndings [15]. Our analysis revealed a number
of ESBLs-producing bacteria and the Gram-negative bacteria
displayed resistance to a variety of antimicrobial agents while
remaining sensitive to ertapenem, tigecycline, and imipenem,
suggesting that these may be the most useful in treating biliary
tract infections caused by Enterobacteriaceae. Our results also
support the practice of collecting and culturing bile samples for
drug sensitivity testing as part of routine cholelithiasis treatment.
Antibiotics should be selected carefully, so as to avoid double
infection and reduce the emergence of resistant strains of
bacteria.
It was found that the largest proportion of cholelithiasis pa-
tients had dampness-heat of the liver and gallbladder according
to TCM, and that pathogenic bacteria were differently distrib-
uted in cholelithiasis patients with different TCM syndromes.
Gram-negative bacteria were detected in the largest proportion
of patients with dampness-heat of the liver and gallbladder,
suggesting that the presence of dampness and heat in the liver
and gallbladder may be a result of Gram-negative bacteria
infection. Different genotypes of the PXR gene were differently
distributed in cholelithiasis patients with different TCM syn-
dromes, suggesting that the PXR rs6785049 genotype could play
a role in determining how cholelithiasis manifests in different
individuals.
Analysis of the rs2276707, rs3814055, and rs6785049
polymorphisms revealed a correlation between the rs6785049
polymorphism and cholelithiasis diagnosis, along with statisti-
cally signiﬁcant differences in GG, GA, and AA genotype dis-
tribution within the rs6785049 polymorphism. After combining
GA and AA, there was still a signiﬁcant difference between the
combined genotype and GG, and logistic regression analysis
showed that compared to those carrying the GG wild type allele,individuals with the GA genotype were at increased risk for
developing gallstones (OR = 0.40); similarly, those carrying
with GA+AA genotype were also at increased risk of gallstones
(OR = 0.38). Findings have indicated that bile acids can activate
PXR, and the activated PXR can reduce cholestasis, bile acid,
and maintain homeostasis of bile acids [16–19]. The mechanism
for this may involve PXR induction of ﬁbroblast growth −19
gene expression, thereby strengthening the recovery of bile
acids, so as to prevent the formation of gallstones.
Bacterial cultures of bile specimens and blood samples
collected from cholelithiasis patients were analyzed and bacteria
types, antibiotic sensitivity of the bacteria, and PXR gene
polymorphisms to samples from healthy patients were
compared. The pathogenic bacteria distribution in patients' bile
and antibiotic resistance characteristics in relation to TCM
syndrome differentiation were also evaluated. The results of our
study support the timely collection of bile samples for bacterial
culture, drug sensitivity testing and the careful selection of an-
tibiotics to prevent double infection and reduce the emergence of
resistant strains. Our results also support a role for PXR gene
rs6785049 polymorphisms in inﬂuencing the expression of the
PXR gene and the development of gallstones, providing an op-
portunity for early detection and prevention at an early stage
through genotype detection. It is also found that gallstone
development is associated with TCM syndrome differentiation,
providing a theoretical basis for the prevention, diagnosis, and
treatment of cholelithiasis.
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